STOCK TITAN

[SCHEDULE 13G/A] British American Tobacco p.l.c. American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Capital Research Global Investors reports beneficial ownership of 192,380,424 shares of British American Tobacco p.l.c. common stock, representing 8.8% of the 2,195,796,448 shares believed outstanding. The filing shows sole voting power over 192,348,927 shares and sole dispositive power over 192,380,424 shares, with no shared voting or dispositive power. Reported holdings include 21,509,702 Depository Receipts that correspond to common stock. The reporting entity is Capital Research Global Investors, organized in Delaware, listing an office in Los Angeles. The statement certifies the holdings are not for the purpose of changing or influencing control of the issuer.

Capital Research Global Investors segnala la titolarità effettiva di 192,380,424 azioni ordinarie di British American Tobacco p.l.c., pari al 8.8% delle 2,195,796,448 azioni ritenute in circolazione. La comunicazione indica il potere di voto esclusivo su 192,348,927 azioni e il potere dispositiv o esclusivo su 192,380,424 azioni, senza alcun potere di voto o di disposizione condiviso. Le partecipazioni segnalate comprendono 21,509,702 certificati depositari (Depositary Receipts) corrispondenti ad azioni ordinarie. L'entità che presenta la dichiarazione è Capital Research Global Investors, costituita nel Delaware e con ufficio a Los Angeles. La dichiarazione attesta che tali partecipazioni non mirano a modificare o a influenzare il controllo dell'emittente.

Capital Research Global Investors informa la propiedad beneficiaria de 192,380,424 acciones ordinarias de British American Tobacco p.l.c., que representan el 8.8% de las 2,195,796,448 acciones que se consideran en circulación. La presentación muestra poder de voto exclusivo sobre 192,348,927 acciones y poder dispositvo exclusivo sobre 192,380,424 acciones, sin ningún poder de voto o dispositvo compartido. Las tenencias informadas incluyen 21,509,702 certificados depositarios (Depositary Receipts) que corresponden a acciones ordinarias. La entidad informante es Capital Research Global Investors, constituida en Delaware y con oficina en Los Ángeles. La declaración certifica que las participaciones no tienen por objeto cambiar o influir en el control del emisor.

Capital Research Global Investors는 British American Tobacco p.l.c. 보통주 192,380,424주의 실질적 보유를 보고했으며, 이는 유통주식수 2,195,796,448주8.8%에 해당합니다. 신고서에는 192,348,927주에 대한 단독 의결권192,380,424주에 대한 단독 처분권을 보유하고 있으며, 공동 의결권 또는 처분권은 없다고 기재되어 있습니다. 보고된 보유에는 보통주에 해당하는 21,509,702개의 예탁증서(Depositary Receipts)가 포함됩니다. 신고 주체는 델라웨어에 설립되어 로스앤젤레스에 사무소를 둔 Capital Research Global Investors입니다. 해당 보유는 발행회사의 지배권을 변경하거나 영향력을 행사하려는 목적이 아님을 확인합니다.

Capital Research Global Investors déclare la propriété effective de 192,380,424 actions ordinaires de British American Tobacco p.l.c., représentant 8.8% des 2,195,796,448 actions estimées en circulation. Le document indique un pouvoir de vote exclusif sur 192,348,927 actions et un pouvoir de disposition exclusif sur 192,380,424 actions, sans aucun pouvoir de vote ou de disposition partagé. Les avoirs déclarés incluent 21,509,702 certificats de dépôt (Depositary Receipts) correspondant à des actions ordinaires. L'entité déclarante est Capital Research Global Investors, constituée dans le Delaware et disposant d'un bureau à Los Angeles. La déclaration certifie que ces avoirs n'ont pas pour but de modifier ou d'influencer le contrôle de l'émetteur.

Capital Research Global Investors meldet wirtschaftliches Eigentum an 192,380,424 Aktien der British American Tobacco p.l.c. Stammaktien, was 8.8% der geschätzten 2,195,796,448 ausstehenden Aktien entspricht. Die Einreichung weist alleinige Stimmrechte über 192,348,927 Aktien und alleinige Verfügungsmacht über 192,380,424 Aktien aus, ohne gemeinsame Stimm- oder Verfügungsmacht. Zu den gemeldeten Beständen gehören 21,509,702 Depositary Receipts, die Stammaktien entsprechen. Die meldende Einheit ist Capital Research Global Investors, im Bundesstaat Delaware organisiert und mit einem Büro in Los Angeles. Die Erklärung bestätigt, dass die Bestände nicht dazu bestimmt sind, die Kontrolle des Emittenten zu ändern oder zu beeinflussen.

Positive
  • Material disclosed stake: Reported beneficial ownership of 192,380,424 shares (8.8%), exceeding the 5% reporting threshold.
  • Clear control of votes: Sole voting power over 192,348,927 shares and sole dispositive power over 192,380,424 shares.
  • Transparency on instruments: Includes 21,509,702 Depository Receipts identified as representing common stock.
Negative
  • None.

Insights

TL;DR: Capital Research discloses a material 8.8% stake (192.38M shares) in British American Tobacco; a significant passive holding with sole voting/dispositive control noted.

The position reported by Capital Research Global Investors represents a material ownership block that exceeds the 5% reporting threshold and therefore is likely to attract investor attention. The filing specifies near-complete sole voting and dispositive power over the reported shares, which gives the manager clear control of how those shares are voted and disposed of on behalf of clients. The inclusion of 21.5M Depository Receipts is notable because it clarifies the form of a portion of the holding. The filing also contains an explicit certification that the shares are not held to influence control, indicating a routine, portfolio-management purpose rather than an activist intent.

TL;DR: An 8.8% beneficial stake signals material ownership but the filer disclaims any intent to change control, suggesting a passive or index-style holding.

The disclosure is material from a governance perspective because an 8.8% stake in a large, widely held issuer creates potential influence over governance outcomes, even if the filer asserts no intent to seek control. The filing’s breakdown—sole voting power of 192,348,927 and sole dispositive power of 192,380,424—means Capital Research can act decisively on voting matters where it chooses to do so. Investors and the issuer will note the position for shareholder meeting dynamics and any future engagement, but the explicit certification frames this as ordinary-course investment activity rather than an activist campaign.

Capital Research Global Investors segnala la titolarità effettiva di 192,380,424 azioni ordinarie di British American Tobacco p.l.c., pari al 8.8% delle 2,195,796,448 azioni ritenute in circolazione. La comunicazione indica il potere di voto esclusivo su 192,348,927 azioni e il potere dispositiv o esclusivo su 192,380,424 azioni, senza alcun potere di voto o di disposizione condiviso. Le partecipazioni segnalate comprendono 21,509,702 certificati depositari (Depositary Receipts) corrispondenti ad azioni ordinarie. L'entità che presenta la dichiarazione è Capital Research Global Investors, costituita nel Delaware e con ufficio a Los Angeles. La dichiarazione attesta che tali partecipazioni non mirano a modificare o a influenzare il controllo dell'emittente.

Capital Research Global Investors informa la propiedad beneficiaria de 192,380,424 acciones ordinarias de British American Tobacco p.l.c., que representan el 8.8% de las 2,195,796,448 acciones que se consideran en circulación. La presentación muestra poder de voto exclusivo sobre 192,348,927 acciones y poder dispositvo exclusivo sobre 192,380,424 acciones, sin ningún poder de voto o dispositvo compartido. Las tenencias informadas incluyen 21,509,702 certificados depositarios (Depositary Receipts) que corresponden a acciones ordinarias. La entidad informante es Capital Research Global Investors, constituida en Delaware y con oficina en Los Ángeles. La declaración certifica que las participaciones no tienen por objeto cambiar o influir en el control del emisor.

Capital Research Global Investors는 British American Tobacco p.l.c. 보통주 192,380,424주의 실질적 보유를 보고했으며, 이는 유통주식수 2,195,796,448주8.8%에 해당합니다. 신고서에는 192,348,927주에 대한 단독 의결권192,380,424주에 대한 단독 처분권을 보유하고 있으며, 공동 의결권 또는 처분권은 없다고 기재되어 있습니다. 보고된 보유에는 보통주에 해당하는 21,509,702개의 예탁증서(Depositary Receipts)가 포함됩니다. 신고 주체는 델라웨어에 설립되어 로스앤젤레스에 사무소를 둔 Capital Research Global Investors입니다. 해당 보유는 발행회사의 지배권을 변경하거나 영향력을 행사하려는 목적이 아님을 확인합니다.

Capital Research Global Investors déclare la propriété effective de 192,380,424 actions ordinaires de British American Tobacco p.l.c., représentant 8.8% des 2,195,796,448 actions estimées en circulation. Le document indique un pouvoir de vote exclusif sur 192,348,927 actions et un pouvoir de disposition exclusif sur 192,380,424 actions, sans aucun pouvoir de vote ou de disposition partagé. Les avoirs déclarés incluent 21,509,702 certificats de dépôt (Depositary Receipts) correspondant à des actions ordinaires. L'entité déclarante est Capital Research Global Investors, constituée dans le Delaware et disposant d'un bureau à Los Angeles. La déclaration certifie que ces avoirs n'ont pas pour but de modifier ou d'influencer le contrôle de l'émetteur.

Capital Research Global Investors meldet wirtschaftliches Eigentum an 192,380,424 Aktien der British American Tobacco p.l.c. Stammaktien, was 8.8% der geschätzten 2,195,796,448 ausstehenden Aktien entspricht. Die Einreichung weist alleinige Stimmrechte über 192,348,927 Aktien und alleinige Verfügungsmacht über 192,380,424 Aktien aus, ohne gemeinsame Stimm- oder Verfügungsmacht. Zu den gemeldeten Beständen gehören 21,509,702 Depositary Receipts, die Stammaktien entsprechen. Die meldende Einheit ist Capital Research Global Investors, im Bundesstaat Delaware organisiert und mit einem Büro in Los Angeles. Die Erklärung bestätigt, dass die Bestände nicht dazu bestimmt sind, die Kontrolle des Emittenten zu ändern oder zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Capital Research Global Investors
Signature:Jae Won Chung
Name/Title:Vice President and Senior Counsel II, Capital Research and Management Company
Date:08/05/2025

FAQ

How many British American Tobacco (BTI) shares does Capital Research report owning?

The filing reports beneficial ownership of 192,380,424 shares of BTI common stock.

What percentage of BTI does the holding represent?

The reported position represents 8.8% of the 2,195,796,448 shares believed to be outstanding.

Does Capital Research have voting control over these shares?

Yes. The filing shows sole voting power over 192,348,927 shares and no shared voting power.

Are any Depository Receipts included in the reported holdings?

Yes. The report includes 21,509,702 Depository Receipts that represent common stock.

Does the filing state an intention to influence control of BTI?

The certification in the filing states the securities are not held for the purpose of changing or influencing control of the issuer.
British Amer

NYSE:BTI

BTI Rankings

BTI Latest News

BTI Latest SEC Filings

BTI Stock Data

126.54B
2.08B
5.27%
10.73%
0.34%
Tobacco
Consumer Defensive
Link
United Kingdom
London